Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
Abstract Background Substandard anti-malarial agents pose a significant challenge to effective malaria control and elimination efforts especially in sub-Saharan Africa. The quality of anti-malarials in most low-and-middle income countries (LMICs) is affected by several factors including inadequate r...
Main Authors: | Moses Ocan, Loyce Nakalembe, Caroline Otike, Denis Omali, Allan Buzibye, Sam Nsobya |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12936-023-04600-8 |
Similar Items
-
Formulation, process development and evaluation of artemether and lumefantrine soft gelatin capsule
by: A Patel, et al.
Published: (2012-01-01) -
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
by: Sileshi Belew, et al.
Published: (2020-04-01) -
Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
by: Joel Tarning, et al.
Published: (2022-10-01) -
Comparison of the efficacy of artemether-lumefantrine vs. artesunate plus sulfadoxine-pyrimethamine in children with uncomplicated falciparum malaria
by: Rachmawati Rachmawati, et al.
Published: (2010-04-01) -
Therapeutic efficacy of artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India
by: Praveen K. Bharti, et al.
Published: (2016-10-01)